Law360, New York (July 02, 2009) -- Teva Pharmaceutical Industries Ltd. is facing a suit by two Bayer AG units over the Israeli generics maker’s plans to launch a generic version of erectile dysfunction drug Levitra.
Bayer Schering Pharma and Bayer HealthCare Pharmaceuticals Inc., along with exclusive licensee Schering Corp., lodged a suit in the U.S. District Court for the District of Delaware on Wednesday after...


